Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases-Reference-Cited by-同舟云学术

Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases

Published:2012-01 Issue:1 Volume:22 Page:456-460
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Suzuki Naoyuki,Shiota Takeshi,Watanabe Fumihiko,Haga Norihiro,Murashi Takami,Ohara Takafumi,Matsuo Kenji,Omori Naoki,Yari Hiroshi,Dohi Keiji,Inoue Makiko,Iguchi Motofumi,Sentou Jyunko,Wada Tooru

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference13 articles.

1. NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer

2. HER2-Positive Breast Cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer;European Journal of Medicinal Chemistry Reports;2024-08

2. Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents;Current Medicinal Chemistry;2024-06-10

3. Anilinopyrimidines: A Review Exploring Synthetic Approaches and Biological Activity;Letters in Organic Chemistry;2023-10

4. Reckoning apigenin and kaempferol as a potential multi-targeted inhibitor of EGFR/HER2-MEK pathway of metastatic colorectal cancer identified using rigorous computational workflow;Molecular Diversity;2022-02-10

5. Design, Synthesis and Biological Evaluation of the Quinazoline Derivatives as L858R/T790M/C797S Triple Mutant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors;Chemical and Pharmaceutical Bulletin;2020-10-01